IVF Hartmann Holding AG Logo

IVF Hartmann Holding AG

0QQM.L

(0.0)
Stock Price

136,00 CHF

7.78% ROA

17.09% ROE

19.07x PER

Market Cap.

249.273.675,00 CHF

0% DER

0% Yield

9.5% NPM

IVF Hartmann Holding AG Stock Analysis

IVF Hartmann Holding AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

IVF Hartmann Holding AG Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

IVF Hartmann Holding AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

IVF Hartmann Holding AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Unknown
2 MACD Unknown
3 RSI Unknown
4 Stoch RSI Unknown

IVF Hartmann Holding AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

IVF Hartmann Holding AG Revenue
Year Revenue Growth
2012 125.998.000
2013 125.434.000 -0.45%
2014 132.939.000 5.65%
2015 132.288.000 -0.49%
2016 134.693.000 1.79%
2017 133.449.999 -0.93%
2018 134.049.000 0.45%
2019 139.021.000 3.58%
2020 173.960.000 20.08%
2021 144.802.000 -20.14%
2022 151.149.000 4.2%
2023 143.136.000 -5.6%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

IVF Hartmann Holding AG Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

IVF Hartmann Holding AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

IVF Hartmann Holding AG EBITDA
Year EBITDA Growth
2012 20.144.000
2013 21.060.000 4.35%
2014 21.602.000 2.51%
2015 21.746.000 0.66%
2016 23.146.000 6.05%
2017 21.969.000 -5.36%
2018 19.419.000 -13.13%
2019 17.645.000 -10.05%
2020 24.964.000 29.32%
2021 11.606.000 -115.1%
2022 18.223.000 36.31%
2023 20.808.000 12.42%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

IVF Hartmann Holding AG Gross Profit
Year Gross Profit Growth
2012 72.520.000
2013 73.236.000 0.98%
2014 76.213.000 3.91%
2015 77.610.000 1.8%
2016 79.207.000 2.02%
2017 78.172.999 -1.32%
2018 74.104.000 -5.49%
2019 73.798.000 -0.41%
2020 93.974.000 21.47%
2021 74.106.000 -26.81%
2022 80.615.000 8.07%
2023 77.830.000 -3.58%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

IVF Hartmann Holding AG Net Profit
Year Net Profit Growth
2012 14.815.000
2013 15.346.000 3.46%
2014 15.777.000 2.73%
2015 16.091.000 1.95%
2016 16.447.000 2.16%
2017 16.010.000 -2.73%
2018 14.070.000 -13.79%
2019 12.169.000 -15.62%
2020 17.825.000 31.73%
2021 6.209.000 -187.08%
2022 11.225.000 44.69%
2023 14.074.000 20.24%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

IVF Hartmann Holding AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 6
2013 6 0%
2014 7 0%
2015 7 0%
2016 7 0%
2017 7 0%
2018 6 -20%
2019 5 0%
2020 8 28.57%
2021 3 -250%
2022 5 50%
2023 6 20%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

IVF Hartmann Holding AG Free Cashflow
Year Free Cashflow Growth
2012 13.029.000
2013 15.258.000 14.61%
2014 12.484.000 -22.22%
2015 16.450.000 24.11%
2016 15.874.000 -3.63%
2017 13.805.000 -14.99%
2018 9.363.000 -47.44%
2019 5.095.000 -83.77%
2020 20.893.000 75.61%
2021 -7.394.000 382.57%
2022 15.523.000 147.63%
2023 2.922.000 -431.25%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

IVF Hartmann Holding AG Operating Cashflow
Year Operating Cashflow Growth
2012 15.815.000
2013 17.775.000 11.03%
2014 16.771.000 -5.99%
2015 20.642.000 18.75%
2016 18.488.000 -11.65%
2017 16.642.000 -11.09%
2018 13.444.000 -23.79%
2019 18.020.000 25.39%
2020 30.888.000 41.66%
2021 -2.511.000 1330.11%
2022 17.719.000 114.17%
2023 3.486.500 -408.22%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

IVF Hartmann Holding AG Capital Expenditure
Year Capital Expenditure Growth
2012 2.786.000
2013 2.517.000 -10.69%
2014 4.287.000 41.29%
2015 4.192.000 -2.27%
2016 2.614.000 -60.37%
2017 2.837.000 7.86%
2018 4.081.000 30.48%
2019 12.925.000 68.43%
2020 9.995.000 -29.31%
2021 4.883.000 -104.69%
2022 2.196.000 -122.36%
2023 564.500 -289.02%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

IVF Hartmann Holding AG Equity
Year Equity Growth
2012 59.504.000
2013 70.290.000 15.34%
2014 81.147.000 13.38%
2015 91.958.000 11.76%
2016 102.885.000 10.62%
2017 113.135.000 9.06%
2018 121.205.000 6.66%
2019 127.374.000 4.84%
2020 139.199.000 8.5%
2021 137.008.000 -1.6%
2022 143.673.000 4.64%
2023 143.265.000 -0.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

IVF Hartmann Holding AG Assets
Year Assets Growth
2012 85.820.000
2013 97.933.000 12.37%
2014 106.455.000 8.01%
2015 120.719.000 11.82%
2016 130.612.000 7.57%
2017 139.453.000 6.34%
2018 149.147.000 6.5%
2019 154.796.000 3.65%
2020 181.088.000 14.52%
2021 173.186.000 -4.56%
2022 180.321.000 3.96%
2023 173.173.000 -4.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

IVF Hartmann Holding AG Liabilities
Year Liabilities Growth
2012 26.316.000
2013 27.643.000 4.8%
2014 25.308.000 -9.23%
2015 28.761.000 12.01%
2016 27.727.000 -3.73%
2017 22.537.000 -23.03%
2018 27.942.000 19.34%
2019 27.422.000 -1.9%
2020 41.889.000 34.54%
2021 36.178.000 -15.79%
2022 36.648.000 1.28%
2023 29.908.000 -22.54%

IVF Hartmann Holding AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
62.38
Net Income per Share
5.51
Price to Earning Ratio
19.07x
Price To Sales Ratio
1.66x
POCF Ratio
12.6
PFCF Ratio
13.93
Price to Book Ratio
1.76
EV to Sales
1.42
EV Over EBITDA
10.92
EV to Operating CashFlow
10.63
EV to FreeCashFlow
11.88
Earnings Yield
0.05
FreeCashFlow Yield
0.07
Market Cap
0,25 Bil.
Enterprise Value
0,21 Bil.
Graham Number
85.96
Graham NetNet
15.02

Income Statement Metrics

Net Income per Share
5.51
Income Quality
1.51
ROE
0.09
Return On Assets
0.13
Return On Capital Employed
0.17
Net Income per EBT
0.85
EBT Per Ebit
1.08
Ebit per Revenue
0.1
Effective Tax Rate
0.15

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.33
Operating Profit Margin
0.1
Pretax Profit Margin
0.11
Net Profit Margin
0.1

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0.45
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
8.33
Free CashFlow per Share
7.45
Capex to Operating CashFlow
-0.11
Capex to Revenue
-0.01
Capex to Depreciation
-0.47
Return on Invested Capital
0.09
Return on Tangible Assets
0.08
Days Sales Outstanding
42.79
Days Payables Outstanding
49.38
Days of Inventory on Hand
128.78
Receivables Turnover
8.53
Payables Turnover
7.39
Inventory Turnover
2.83
Capex per Share
-0.88

Balance Sheet

Cash per Share
16,91
Book Value per Share
59,65
Tangible Book Value per Share
58.29
Shareholders Equity per Share
59.65
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-1.88
Current Ratio
5.03
Tangible Asset Value
0,14 Bil.
Net Current Asset Value
0,10 Bil.
Invested Capital
0
Working Capital
0,10 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
24388000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

IVF Hartmann Holding AG Dividends
Year Dividends Growth

IVF Hartmann Holding AG Profile

About IVF Hartmann Holding AG

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy services, incontinence management, and first aid products, as well as various courses. It serves private doctors; outpatient medicine and care; hospitals and clinics; pharmacies and drugstores; nursing homes; and medical and food retailers, as well as industrial customers. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland.IVF Hartmann Holding AG operates as a subsidiary of Paul Hartmann Finance B.V.

CEO
Dr. Claus Martini
Employee
306
Address
Victor-von-Bruns-Strasse 28
Neuhausen am Rheinfall, 8212

IVF Hartmann Holding AG Executives & BODs

IVF Hartmann Holding AG Executives & BODs
# Name Age
1 Dr. Claus Martini
Chief Executive Officer
70
2 Dr. Hannes Leu
Chief Financial Officer
70
3 Mr. Bernd Deny
Chief Operations Officer
70

IVF Hartmann Holding AG Competitors